Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
45 /100
MEDIUM RISK
Score updated Aug 28, 2026

GLMD — Galmed Pharmaceuticals Ltd. Dilution Risk Tracker

Track GLMD dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track GLMD — Get alerts when the score changes →

As of August 28, 2026, Galmed Pharmaceuticals Ltd. (GLMD) has a DilutionWatch DilutionScore of 45/100, rated MEDIUM dilution risk. Galmed Pharmaceuticals Ltd. has a market capitalization of $4.97M, 6.58M shares outstanding, 10 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
25
📊 Float Risk
15
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 27%
🔄 Reverse Split model est. 55%
• 50-day avg $0.62 below $1 exchange minimum
🔔 Track GLMD — Get forecast alerts →

Market Data

Market Cap$4.97M
Shares Outstanding6.58M
Float6.37M
Cash$10.98M
DebtN/A
Short InterestN/A

Institutional Holdings

10 institutional holders · 221.6K shares
#1 Two Sigma Investments, LP 112.1K shares
#2 Citadel Advisors Llc 38.2K shares
#3 Two Sigma Advisers, LP 31.5K shares
+ 7 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest147.0K
Days to Cover1.0
% of Float2.3%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2015-12-31
EFFECT EFFECT 2026-04-01
3 FORM3 2026-03-18
3 FORM3 2026-03-18
3 FORM3 2026-03-18
Full SEC filing analysis available with free account

Recent News

No recent news

Factual GLMD Dilution Snapshot

Galmed Pharmaceuticals Ltd. (GLMD) has a DilutionScore of 45/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track GLMD Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking GLMD — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for GLMD
GLMD FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.